Protect Pharmaceutical Corporation
PRTT
$1.24
-$0.06-4.62%
06/30/2018 | 03/31/2018 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | -- | -- | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | -- | -- | |||
Operating Income | -- | -- | |||
Income Before Tax | -18.92% | 5.13% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -18.92% | 5.13% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -18.92% | 5.13% | |||
EBIT | -- | -- | |||
EBITDA | -- | -- | |||
EPS Basic | -17.65% | 2.86% | |||
Normalized Basic EPS | -19.05% | 4.55% | |||
EPS Diluted | -17.65% | 2.86% | |||
Normalized Diluted EPS | -47.06% | 22.73% | |||
Average Basic Shares Outstanding | 0.00% | 0.00% | |||
Average Diluted Shares Outstanding | -18.18% | 22.21% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |